Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Singh, Ajaypal
One or more keywords matched the following items that are connected to Singh, Ajaypal
Item TypeName
Concept Immunologic Factors
Concept Parent-Child Relations
Concept Immunosuppressive Agents
Concept Opioid-Related Disorders
Concept Drug-Related Side Effects and Adverse Reactions
Concept Dose-Response Relationship, Drug
Concept Immunohistochemistry
Academic Article Immunopathogenesis of lupus and lupus nephritis: recent insights.
Academic Article Strategies for preservation of ovarian and testicular function after immunosuppression.
Academic Article Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
Academic Article The FDA black box for EPO: what should nephrologists do?
Academic Article Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease.
Academic Article Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Academic Article Endothelial activation markers in anemic non-dialysis chronic kidney disease patients.
Academic Article The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Academic Article Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article Posttransplant anemia: the role of sirolimus.
Academic Article Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.
Academic Article ASN clinicopathologic conference.
Academic Article Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
Academic Article Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Academic Article Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
Academic Article Cause of Death in Patients With Diabetic CKD Enrolled in the?Trial to Reduce Cardiovascular Events With Aranesp Therapy?(TREAT).
Academic Article C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
Academic Article Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
Academic Article Adverse events associated with percutaneous enteral access.
Academic Article Disclosure of the HIV infection status in children.
Academic Article Does Prescription Length of Buprenorphine Influence Treatment Outcomes in Opioid Use Disorder? A Retrospective Cohort Study from North India.
Academic Article Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials.
Academic Article Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply.
Search Criteria
  • Immune
  • related
  • adverse
  • events